Revvity, Inc. RVTY
Free
No email, no account, no signup.
General analysis — not personal advice.
Bull
Bear
Want to follow Revvity, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow 3 companies freeEmail when the signal or risk changes · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Exchange
NYSE
Type
Biotech
Sector
Health science solutions and diagnostics
Price & valuation
Last close
USD 116
1 week
+0.6 %
3 months
+21.8 %
12 months
+31.5 %
From 52w high
-1.7 %
From 52w low
+40.7 %
Market sentiment
Sentiment has modestly improved following the FDA news; commentary is mainly focused on the product catalyst and Q1 execution, while the stock has remained volatile without clear signs of extreme risk-on/risk-off positioning.
We're already tracking Revvity, Inc. — here are the latest events we've registered
Recent News
- Since the Q1 release (May 5), Revvity received FDA clearance (May 13) for its Total Testosterone Assay for automated ChLIA, enabling a more comprehensive testosterone testing menu on a single platform. The company is still planning to divest its China Immunodiagnostics business (~6% of 2025 revenue) with expected completion in 2027; no new financial reports have been issued and the next expected report is July 27, 2026 (Q2).
What Firelda Watch includes for Revvity, Inc.
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — AI roundup of the week's news
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Revvity, Inc. will be delivered in the same format.
Want to follow Revvity, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow 3 companies freeEmail when the signal or risk changes · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.